Results 161 to 170 of about 51,855 (253)

Becoming a Different Person: Living with Hepatic Encephalopathy as a Condition in Everyday Life-A Qualitative Explorative Study. [PDF]

Healthcare (Basel)
Hamberg MLS, Werge RP, Lauridsen SV, Thomsen TS.   +3 more
europepmc   +1 more source

Vectors and Vector‐Borne Diseases: Biology, Epidemiology and Integrated Control Strategies

Journal of Applied Entomology, Volume 150, Issue 7, Page 990-1015, August 2026.
ABSTRACT Vector‐Borne Diseases (VBDs), transmitted by arthropods such as mosquitoes, ticks, fleas and sandflies, represent a significant threat to global health. These diseases can be caused by a variety of pathogens, including bacteria, viruses, protozoa, and helminths.
Roberta Rinaldi, Carmen Scieuzo, Federica De Stefano, Luca Masucci, Patrizia Falabella   +4 more
wiley   +1 more source

Pathomechanism of Fever‐Induced Liver Failure in NBAS Deficiency and Treatment Effect of NAC—Observations In Vitro and In Vivo

Liver International, Volume 46, Issue 8, August 2026.
ABSTRACT Background and Aims Pathogenic variants in neuroblastoma amplified sequence (NBAS) gene causes infantile liver failure type 2 (IFLS2; MIM 616483), characterised by recurrent episodes of liver failure triggered by febrile infections. The underlying pathophysiological mechanisms remain incompletely understood. With this work we try to shed light
Tian Sun, Nicole Hammann, Lina Leghlam, Bianca Peters, Cigdem Arikan, Sarah M. Bedoyan, Qian Chen, Tal Dattner, Felix Distelmaier, Alexander Fichtner, Sven F. Garbade, Nedim Hadžić, Robert Hegarty, Andrea Hellwig, Marianne Hørby Jørgensen, Carolin Jentsch, Sabine Jung‐Klawitter, Martin Laass, Elke Lainka, Hannah Münch, Halise Neslihan Önenli Mungan, Moritz Niesert, Stephanie Oehrl, Begona Polo, Knut Schäkel, James E. Squires, Stefan Kölker, Georg F. Hoffmann, Christian Staufner, Dominic Lenz   +29 more
wiley   +1 more source

Sociodemographic disparities in documented nonadherence to medication for hepatic encephalopathy: a National Inpatient Sample analysis. [PDF]

Ann Gastroenterol
Behrend C, Ali Y, Akambase JA, Goble SR, Leventhal TM.   +4 more
europepmc   +1 more source

Enhanced Liver Fibrosis Test, FIB‐4 and FibroScan: Real‐World Prognostic Accuracy for MASLD in a Biopsy‐Controlled Cohort

Liver International, Volume 46, Issue 8, August 2026.
ABSTRACT Background and Aims Liver fibrosis is a major determinant of liver‐related events (LREs) in patients with metabolic dysfunction‐associated steatotic liver disease (MASLD). Effective stratification based on fibrosis severity is essential for accurate prognosis.
Antonio Liguori, Francesca D'Ambrosio, Giulia Angelini, Consuelo Cefalo, Simone Galletti, Sara Cardinali, Maria Cristina Giustiniani, Giuseppe Marrone, Marco Biolato, Gianludovico Rapaccini, Maurizio Pompili, Antonio Grieco, Tommaso Mazza, Andrea Urbani, Maurizio Sanguinetti, Antonio Gasbarrini, FPG‐UCSC PROMETEO‐ELF substudy Research Group, Luca Miele   +17 more
wiley   +1 more source

The role of systemic inflammation in hepatic encephalopathy: advances in inflammatory mechanisms, prevention and treatment research. [PDF]

Ann Med
Wang W, Wen Y.
europepmc   +1 more source

Changes in SSM Assessed via 100 Hz‐VCTE Are Associated With Acute HVPG‐Response to i.v. Propranolol: A European Multicentre Study

Liver International, Volume 46, Issue 8, August 2026.
ABSTRACT Background The acute hepatic venous pressure gradient (HVPG)‐response to i.v. propranolol predicts outcomes in patients with advanced chronic liver disease (ACLD) and clinically significant portal hypertension (CSPH). While non‐invasive tests (NIT) to monitor non‐selective beta‐blocker (NSBB)‐induced HVPG changes are lacking, spleen stiffness ...
Paul Thöne, Dario Saltini, Joana Calvão, Lorenz Balcar, Tomas Guasconi, Georg Semmler, Paula Höfinger, Barbara Datterl, Albert Friedrich Stättermayer, Michael Trauner, Thomas Reiberger, José Presa, Filippo Schepis, Mattias Mandorfer, Mathias Jachs   +14 more
wiley   +1 more source

Evaluation of Quality of Life and Risk Factors in Patients With Covert Hepatic Encephalopathy Including Those With Hepatocellular Carcinoma. [PDF]

Cancer Diagn Progn
Ishikawa T, Ito R, Arita N, Matsuhashi Y, Honma T.   +4 more
europepmc   +1 more source

Neurofilament Light Chain in Cerebrospinal Fluid and Blood Identifies Patients With Minimal and Overt Hepatic Encephalopathy

Liver International, Volume 46, Issue 8, August 2026.
ABSTRACT Background Minimal hepatic encephalopathy (MHE) is an underdiagnosed complication of liver cirrhosis, associated with progression to overt hepatic encephalopathy (HE). The Portosystemic Hepatic Encephalopathy Score (PHES) is the recommended diagnostic standard, but its use is hindered by resource constraints and limited accuracy. Neurofilament
Elise Jonasson, Lea L. Grønkjær, Birgitte G. Jacobsen, Dorte A. Olsen, Charlotte W. Wernberg, Jens Kuhle, Jonna S. Madsen, Tobias Sejbaek, Mette M. Lauridsen   +8 more
wiley   +1 more source

Clinical Challenges in the Management of Hepatic Encephalopathy in Older Patients with Cirrhosis: A Nationwide Italian Physician-Reported Survey. [PDF]

Medicina (Kaunas)
Lapenna L, Di Cola S, Nardelli S, Merli M.   +3 more
europepmc   +1 more source